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Abstract
BACKGROUND: In vulvar cancer, in a large portion of patients
with early stages of the disease, the inguinal lymphadenecto-
my not only does not influence the overall survival and recur-
rence rate but may increase the incidence of complications.
Sentinel lymph node (SN) detection is a promising technique
for detecting groin lymph nodes, which may in future lead to
less extensive use of surgical treatment. The aim of the study
was to evaluate the feasibility of the sentinel node detection
technique in patients with vulvar cancer.
MATERIAL AND METHODS: Between the years 2003 and 2005,
we performed intraoperative lymphatic mapping on 10 patients
with planoepithelial vulvar cancer. In eight cases, vulvar lesion
was localized centrally, around the clitoris. The extent of the
surgery included radical vulvectomy with bilateral inguinal lym-
phadenectomy in nine cases and unilateral inguinal lym-
phadenectomy in one case. For the lymphatic mapping, we
employed two detection methods: 99mTc-labelled radiocolloid
(activity 3570 MBq) and blue dye (35 ml). Both techniques
were used in six cases (60%), blue dye only in three cases and
radiocolloid only in one case.
RESULTS: In each patient, we detected at least one sentinel
lymph node. Sentinel nodes were localized in 14 of 19 opera-
ted groins (73.7%); a total of 25 SNs in all. The mean number of
SNs for one groin was 1.78. Nodal metastases were found in
four cases. In three cases, metastases were detected only in
the SN. In one patient, two SNs with metastases were found in
one groin and in the contralateral groin (without any SN) there
Correspondence to: Dariusz Wydra
Department of Gynaecology, Medical University
ul. Kliniczna 1 A, 80402 Gdaæsk, Poland
Tel: (+48) 509 905 500, fax: (+48 58) 341 80 03
e-mail: dwydra@amg.gda.pl
was one unchanged node, which transpired to be metastatic.
This can be explained by a complete overgrowth of neoplasm
in the lymph node resulting in lymph flow stasis and disabling
tracer uptake. In five cases, an SN was found only in one groin
 the first case is described above, in the second case the
vulvar tumor was localized laterally, opposite to the groin with-
out any SN. In the remaining three cases, we have used only
one method of SN detection.
CONCLUSIONS: Lymphatic mapping in vulvar cancer based
on the combined detection technique is a highly accurate met-
hod after adequate training of the surgeons.
Key words: vulvar cancer, sentinel lymph node
Introduction
At present, the standard surgical approach in vulvar cancer is
the radical vulvectomy or hemivulvectomy with inguinofemoral lym-
phadenectomy. In this disease, metastatic cells initially spread through
the lymphatic system. Inguinal lymph node metastases are the most
important prognostic factor in vulvar cancer [1]. Due to the lack of
a satisfactory method of preoperative evaluation of the inguinal lymph
nodes status, inguinal lymphadenectomy is still the standard me-
thod of treatment. The main disadvantage of the inguinal lym-
phadenectomy is that it significantly increases the morbidity and
mortality of the surgical treatment. Metastatic disease in inguinal lymph
nodes depends on the vulvar tumor diameter and the depth of neo-
plastic infiltration. In lesions smaller than one centimetre, lymph node
metastases are present in approximately 18% of cases [1].
For this reason, in a large proportion of patients with early stage
disease, the lymphadenectomy does not influence the overall survival
and recurrence rate but increases the treatment complication rate.
Sentinel lymph node (SN) detection is a promising technique
showing groin lymph nodes in patients with early vulvar cancer. In
most published studies, the SN detection rate reaches 100% [2
4] with only six reported cases of false negative sentinel nodes
[47]. After future validation of this technique, lymphatic mapping
will lead to less extensive surgical treatment.
The aim of the study was to evaluate of the feasibility of the
sentinel node detection technique in patients with vulvar cancer.
Material and methods
Between years 2003 and 2005, we performed intraoperative
lymphatic mapping on ten patients with planoepithelial vulvar can-
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cer. Characteristics of  patients is shown on Table 1. The study
was approved by the Local Ethical Comittee and all patients signed
an informed consent before enrolment.
Tumor size according to TNM staging was: T1 lesions
 4 cases, T2 lesions  6 cases.
In eight cases, the vulvar lesion was localized centrally, around
the clitoris. In the remaining two cases, the tumour was located
laterally.
The extent of the surgery included radical vulvectomy with bi-
lateral inguinal lymphadenectomy in nine cases, and unilateral
inguinal lymphadenectomy in one case. Additionally, in four ca-
ses, pelvic lymphadenectomy was performed.
For the lymphatic mapping, we employed two detection me-
thods: Tc99m labelled radiocolloid (Amersham Sorin, Italy) and blue
dye (Methylenblau Vitis, Neopharma, Chiemgau, Germany). Both
techniques were used in six cases, blue dye injection only in three
cases and radiocolloid injection in one case.
Radiocolloid was injected intradermally around the tumor (to-
tal dose 3570 MBq) under local anaesthesia 15 to 120 minutes
before surgery. Blue dye (35 ml) was injected after general an-
aesthesia, approximately 15 minutes before the operation.
Sentinel lymph nodes were localized using a hand held gam-
ma probe and direct visualization. All radioactive or coloured in-
guinal lymph nodes were regarded as the sentinel nodes. All re-
moved inguinal nodes were evaluated during standard patholo-
gical examination.
Results
In each patient, we have detected at least one sentinel lymph
node. A description of each case is presented in Table 2. Sentinel
nodes were localized in 14 of 19 operated groins (73.7%), in all
a total 25 SN. The mean number of SN for one groin was 1.78.
Nodal metastases were found in four patients (cases no. 1, 3,
4, 5). In three cases, metastases were located only in the sentinel
nodes. In the one remaining patient (case no. 1) there were two
SNs with metastases in the right groin, and in the left groin there
was one metastatic lymph node which was not visualised as an
SN. This case will be discussed later on.
In case number four, in one groin two SNs were found using
both detection techniques. Unexpectedly, nodal metastasis was
diagnosed at less radioactive and less intensive blue dye uptake.
We analysed five cases where we could not detect any SN in
either of the operated groins. In the first case (no. 1), only one
metastatic non-sentinel node was found as previously described.
In the second case (no. 2), vulvar lesion was located unilaterally.
Following the principles of lymph flow from the vulva [8], we did
not expect to find the SN in the contralateral groin. In the remain-
ing three cases (no. 3, 7, 8), we employed only one detection
method.
We also compared results obtained with each detection me-
thod. With the blue dye, we were able to find SNs in 12 of 17 groins
(70.5%), with a total of 18 SNs detected (1.5 SNs per groin).
Using radiocolloid tracer, we achieved a detection rate of 83.3%
(SNs found in 10 of 12 groins), with a mean of 1.7 SN per groin.
Discussion
The present study confirms the accuracy of lymphatic map-
ping in the vulvar cancer. Although we were able to detect an SN
in each patient with no false negative cases, we have encoun-
tered some difficulties, which show important limitations to this
technique.
In 80% of cases, vulvar lesion was localised in the midline. In
such cases, lymph drainage from the tumor can reach both
groins, which implies the need for bilateral SN detection [8]. In
our study, we were unable to find SNs in both groins in four ca-
ses with centrally located lesion. The most interesting of these is
case no. 1, in which we found two SNs on the right side, both
containing neoplastic cells and on the left side only one meta-
static node without any tracer uptake. As the two SNs in the right
groin contained the only metastasis for this group of inguinal
Table 1. Characteristics of patients enrolled in the study
Mean value Range
Patient age [year] 66 3776
Operation time [min] 189.5 150240
Hospital stay duration [day] 29.5 1369
Table 2. Characteristics of ten cases of sentinel node detection in vulvar cancer
Case no. Tumour Lymphadenectomy Blue Tc99m Right side Left side
localization dye SN SN no. SN + Inguinal SN SN no.   SN +  Inguinal
nodes + nodes +
1 Midline Bilateral 1 1 1 2 1 0 0 0 0 1
2 Lateral Bilateral 1 1 0 0 0 0 1 2 0 0
3 Midline Bilateral 1 0 0 0 0 0 1 2 1 0
4 Midline Bilateral 1 1 1 2 0 0 1 2 1 0
5 Midline Bilateral 1 1 1 1 0 0 1 2 1 0
6 Midline Bilateral 1 1 1 3 0 0 1 2 0 0
7 Midline Bilateral 1 0 0 0 0 0 1 1 0 0
8 Midline Bilateral 0 1 1 1 0 0 0 0 0 0
9 Lateral Unilateral 1 1 N/A N/A N/A N/A 1 1 0 0
10 Midline Bilateral 1 0 1 2 0 0 1 2 0 0
N/A  not attending
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lymph nodes, this case does not deny efficacy of this technique.
The single metastatic node found on the left side can be regard-
ed as a missing sentinel node. Failure of the tracer to pass
through the lymphatics to the lymph node can be explained by
a complete overgrowth of the neoplastic process in this node. In
the literature there are cases available presenting identical clini-
cal findings in vulvar cancer [3, 4, 9, 10] and in large breast
cancer trials [11, 12]. Thus in the case of centrally located vulvar
cancer without bilateral SN detection it should be treated as
a failure in lymphatic mapping.
As mentioned before, there were another three cases of me-
dial vulvar lesion where we failed to find SN in one groin. Although
there were no metastases in the groins without SNs, those results
are unsatisfactory. We suggest that there are two explanations for
those results. Firstly, in all three cases we used only one detection
technique (blue dye in two, radionuclide in one). Secondly, this
study reports our initial experience with lymphatic mapping in vul-
var cancer and there certainly exists a learning-curve which influ-
ences detection rates when beginning to use this procedure.
According to de Hullu [13] the minimal number of cases neces-
sary to achieve reliable results in vulvar cancer is at least ten cases
(1520 groins).
Due to the small number of cases in the present study, it is
not possible to compare the effectiveness of each detection
method. Although it seems that the radiocolloid tracer offers
a better SN detection technique, in order to obtain the highest
diagnostic accuracy use of the combined technique seems to
be most suitable.
In case no. 4, two separate SNs were detected in one groin,
both blue and radioactive. Unexpectedly, neoplastic cells were
found in the node with lower radioactivity and less intensive blue
dye uptake (so-called echelon-node). This finding shows that
after removal of the first SN it is imperative to look carefully for any
potential echelon-nodes remaining in the groin. For this purpose,
the most suitable technique is the intraoperative hand-held ga-
mma-probe, which allows us to avoid extensive dissection of the
groins. Moreover, it is necessary to perform an intraoperative patho-
logic examination of all removed nodes in order to get reliable
information about the inguinal lymph nodes status.
Conclusions
1. Lymphatic mapping in vulvar cancer based on the combined
detection technique is a highly accurate method after ade-
quate training of surgeons.
2. After removal of the SN it is necessary to exclude the pre-
sence of additional echelon-nodes in the dissected groin.
3. In the case of centrally located vulvar tumours, it is imperative
to detect an SN in both groins.
4. Due to the satisfactory results of preliminary studies on senti-
nel node detection in vulvar cancer, a multi-centre, random-
ized study should be performed in future.
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